{
    "response": "**Overall Treatment Decision:** Yes\n\n**Specific Treatment Recommendations:**\n\n*   **Treatment:** Intravenous Methylprednisolone\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** Standard acute treatment for inflammatory demyelinating relapse Urgency dictated by severity of visual and motor deficits\n\n*   **Treatment:** Gastroprotection (e.g., Proton Pump Inhibitor)\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** To prevent corticosteroid-induced gastritis/peptic ulceration\n\n*   **Treatment:** Disease Modifying Therapy (e.g., Ocrelizumab, Natalizumab)\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Requires confirmed diagnosis (MS vs NMOSD require different agents) Requires completion of infection screening (e.g., Hepatitis, TB)\n\n*   **Treatment:** Plasma Exchange (PLEX)\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Second-line rescue therapy if no significant improvement with initial steroid pulse\n\n\ntreatments = [{\"treatment\": \"Intravenous Methylprednisolone\", \"timing\": \"Start Now\", \"reasons\": [\"Standard acute treatment for inflammatory demyelinating relapse\", \"Urgency dictated by severity of visual and motor deficits\"]}, {\"treatment\": \"Gastroprotection (e.g., Proton Pump Inhibitor)\", \"timing\": \"Start Now\", \"reasons\": [\"To prevent corticosteroid-induced gastritis/peptic ulceration\"]}, {\"treatment\": \"Disease Modifying Therapy (e.g., Ocrelizumab, Natalizumab)\", \"timing\": \"Delay\", \"reasons\": [\"Requires confirmed diagnosis (MS vs NMOSD require different agents)\", \"Requires completion of infection screening (e.g., Hepatitis, TB)\"]}, {\"treatment\": \"Plasma Exchange (PLEX)\", \"timing\": \"Delay\", \"reasons\": [\"Second-line rescue therapy if no significant improvement with initial steroid pulse\"]}]"
}